A Novel Machine Learning Approach for Central Nervous System Tumor Classification from DNA Methylation
- URL: http://arxiv.org/abs/2607.01307v1
- Date: Wed, 01 Jul 2026 16:57:58 GMT
- Title: A Novel Machine Learning Approach for Central Nervous System Tumor Classification from DNA Methylation
- Abstract summary: NA methylation profiling has become a powerful approach for central nervous system ( CNS) tumor classification.<n>We propose a novel and methodologically rigorous machine-learning approach for methylation-based CNS tumor classification.<n>Our results show that the proposed model consistently outperforms the previous state of the art across evaluation settings.
- Score: 0.0
- License: http://creativecommons.org/licenses/by-nc-nd/4.0/
- Abstract: NA methylation profiling has become a powerful approach for central nervous system (CNS) tumor classification, yet important challenges remain regarding cross-cohort transferability, methodological correctness, and robust multiclass evaluation. In this work, we propose a novel and methodologically rigorous machine-learning approach for methylation-based CNS tumor classification that combines Sparse Random Projection for dimensionality reduction with multinomial logistic regression for classification. We evaluate the proposed approach in the same general experimental setting established by a widely used reference classifier. On the 2,801-sample reference cohort, our method achieves a mean accuracy of 96\% under stratified 3-fold cross-validation. On the independent 1,104-sample clinical evaluation cohort, it reaches 86\% accuracy at the 91-class level and 93\% when predictions are evaluated at the methylation class family level. These results improve upon the corresponding state-of-the-art reference figures of 82\% class-level concordance and 88\% family-level concordance, yielding absolute gains of approximately 4 and 5 percentage points, respectively. This improvement is clinically relevant: in a diagnostic setting, a 5-point increase in correct tumor classification can directly affect cancer subtype assignment and, in turn, influence treatment selection and downstream clinical decision-making. Our results show that the proposed model, grounded in stronger methodological practice in machine learning, consistently outperforms the previous state of the art across evaluation settings and can materially improve the reliability of CNS tumor classification.
Related papers
- Histopathological Spectrum-Guided Prostate Stratification via Segmentation-Assisted Diagnostic Transformer [29.021037203684227]
We construct a Prostate Cancer Histopathology Spectrum dataset (PCa-HSD)<n>We formulate a clinically meaningful four-class classification task, addressing the underrepresentation of benign lesions that are easily confounded with prostate cancer in existing datasets.<n>Our proposed method consistently improves accuracy across backbones, achieving the best average accuracy of 0.633 and JointRecall of 0.768 in five-fold cross-validation on a cohort of 344 patients.
arXiv Detail & Related papers (2026-07-19T10:03:47Z) - A deep learning pipeline for PAM50 subtype classification using histopathology images and multi-objective patch selection [0.2958068627971103]
The PAM50 gene signature is widely recognized as a standard for classifying breast cancer into intrinsic subtypes.<n>In this study, we introduce a novel optimization-driven deep learning framework that aims to reduce reliance on costly molecular assays.<n>Our method jointly optimize patch informativeness, spatial diversity, uncertainty, and patch count by combining the non-dominated sorting genetic algorithm II (NSGA-II) with Monte Carlo dropout-based uncertainty estimation.
arXiv Detail & Related papers (2026-04-02T09:13:24Z) - Deep Learning-Based Multiclass Classification of Oral Lesions with Stratified Augmentation [0.25489046505746704]
This research intends to use deep learning to build a multiclass classifier for sixteen different oral lesions.<n>The experimental results, which achieved 83.33 percent accuracy, 89.12 percent precision, and 77.31 percent recall, demonstrate the superiority of the suggested model.
arXiv Detail & Related papers (2025-11-26T16:56:42Z) - Fusion-Based Brain Tumor Classification Using Deep Learning and Explainable AI, and Rule-Based Reasoning [0.0]
This study presents an ensemble-based deep learning framework that combines MobileNetV2 and DenseNet121 convolutional neural networks (CNNs)<n>The models were trained and evaluated on the Figshare dataset using a stratified 5-fold cross-validation protocol.<n>The ensemble achieved superior performance compared to individual CNNs, with an accuracy of 91.7%, precision of 91.9%, recall of 91.7%, and F1-score of 91.6%.
arXiv Detail & Related papers (2025-08-09T08:46:36Z) - CIMIL-CRC: a clinically-informed multiple instance learning framework for patient-level colorectal cancer molecular subtypes classification from H\&E stained images [42.771819949806655]
We introduce CIMIL-CRC', a framework that solves the MSI/MSS MIL problem by efficiently combining a pre-trained feature extraction model with principal component analysis (PCA) to aggregate information from all patches.
We assessed our CIMIL-CRC method using the average area under the curve (AUC) from a 5-fold cross-validation experimental setup for model development on the TCGA-CRC-DX cohort.
arXiv Detail & Related papers (2024-01-29T12:56:11Z) - Learning to diagnose cirrhosis from radiological and histological labels
with joint self and weakly-supervised pretraining strategies [62.840338941861134]
We propose to leverage transfer learning from large datasets annotated by radiologists, to predict the histological score available on a small annex dataset.
We compare different pretraining methods, namely weakly-supervised and self-supervised ones, to improve the prediction of the cirrhosis.
This method outperforms the baseline classification of the METAVIR score, reaching an AUC of 0.84 and a balanced accuracy of 0.75.
arXiv Detail & Related papers (2023-02-16T17:06:23Z) - Multi-Scale Input Strategies for Medulloblastoma Tumor Classification
using Deep Transfer Learning [59.30734371401316]
Medulloblastoma is the most common malignant brain cancer among children.
CNN has shown promising results for MB subtype classification.
We study the impact of tile size and input strategy.
arXiv Detail & Related papers (2021-09-14T09:42:37Z) - Medulloblastoma Tumor Classification using Deep Transfer Learning with
Multi-Scale EfficientNets [63.62764375279861]
We propose an end-to-end MB tumor classification and explore transfer learning with various input sizes and matching network dimensions.
Using a data set with 161 cases, we demonstrate that pre-trained EfficientNets with larger input resolutions lead to significant performance improvements.
arXiv Detail & Related papers (2021-09-10T13:07:11Z) - Cancer Gene Profiling through Unsupervised Discovery [49.28556294619424]
We introduce a novel, automatic and unsupervised framework to discover low-dimensional gene biomarkers.
Our method is based on the LP-Stability algorithm, a high dimensional center-based unsupervised clustering algorithm.
Our signature reports promising results on distinguishing immune inflammatory and immune desert tumors.
arXiv Detail & Related papers (2021-02-11T09:04:45Z) - Comparison of Machine Learning Classifiers to Predict Patient Survival
and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM)
We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients.
xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
arXiv Detail & Related papers (2021-02-10T15:10:37Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.